Latest News about ATAI
Recent news which mentions ATAI
From Benzinga
From Benzinga
Atai's Phase 2 Study For Treatment-Resistant Depression Completes Enrollment, Expects Results Soon
October 26, 2022
Tickers
ATAI
From Benzinga
Psychedelic Stock Gainers And Losers From October 26, 2022
October 26, 2022
From Benzinga
20-year-old investor who made $110 million on a meme stock is pushing for change at a psychedelics company
October 26, 2022
From MarketWatch
Psychedelic Stock Gainers And Losers From October 25, 2022
October 25, 2022
From Benzinga
From Benzinga
Allied, Small Pharma Among Top Psychedelic Movers Of Today
October 21, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
October 19, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From October 18, 2022
October 18, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
October 18, 2022
From Benzinga
Atai Launches Phase 1 Clinical Trial On Novel Direct-To-Brain Drug Delivery Technology
October 18, 2022
Tickers
ATAI
From Benzinga
Psychedelic Stock Gainers And Losers From October 17, 2022
October 17, 2022
From Benzinga
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
October 14, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From October 12, 2022
October 12, 2022
From Benzinga
Numinus Wellness, Small Pharma Among Top Psychedelic Movers Of Today
October 11, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From October 10, 2022
October 10, 2022
From Benzinga
Psyched: CA's Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More
October 07, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From October 6, 2022
October 06, 2022
From Benzinga
Allied, GH Research Among Top Psychedelic Movers Of Today
October 04, 2022
From Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
October 03, 2022
From Benzinga
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
September 30, 2022
From Benzinga
Psyched: Autopsy Reveals Death By Ketamine, LSD-Like Drugs Without Hallucinations, DEA & Right To Try Psilocybin
September 30, 2022
From Benzinga
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
September 29, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From September 28, 2022
September 28, 2022
From Benzinga
Biomind Labs, Allied Among Top Psychedelic Movers Of Today
September 27, 2022
From Benzinga
Atai's New MDMA-Based EMP-01 Compound Moves Forward To The Clinical Stage
September 27, 2022
Tickers
ATAI
From Benzinga
Is Now a Good Time to Invest In Psychedelics Stocks?
September 27, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.